NCT03453086

Brief Summary

The investigators hypothesize that the analgesic efficacy of ultrasound-guided serratus anterior plane block will provide better analgesia with fewer complications in comparison to ultrasound guided thoracic paravertebral block

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2018

Shorter than P25 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 29, 2017

Completed
6 days until next milestone

Study Start

First participant enrolled

January 4, 2018

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 8, 2018

Completed
4 days until next milestone

Study Completion

Last participant's last visit for all outcomes

February 12, 2018

Completed
21 days until next milestone

First Posted

Study publicly available on registry

March 5, 2018

Completed
Last Updated

March 16, 2018

Status Verified

March 1, 2018

Enrollment Period

1 month

First QC Date

December 29, 2017

Last Update Submit

March 14, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • First pain medication request

    Time to the first pain medication request till application of the block

    24 hours

Secondary Outcomes (4)

  • Time of pain onset

    24 hours

  • Hemodynamics (heart rate)

    24 hours

  • Hemodynamics (ABP)

    24 hours

  • Nausea and vomiting

    24 hours

Study Arms (2)

Group I:

ACTIVE COMPARATOR

These patients will receive single ipsilateral Ultrasound TPVB which performed with the patient in the sitting position at the level of the T4 with the probe in a vertical position 2.5-3 cm lateral to the midline. The midpoint of the transducer is to be placed in a longitudinal paramedian plane between two transverse processes which visualized with the superior costo-transverse ligament and the pleura visible in between . After this, 15-20 cc of bupivacaine 0.25% will be injected

Procedure: Thoracic paravertebral block(TPVB) group

Group II :

ACTIVE COMPARATOR

These patients will receive serratus anterior plane block. The block will be performed while the patient is in the supine position by using a linear Ultrasound probe of high frequency (6-13 MHz) after sheathing. The probe will be placed over the mid-clavicular region of the thoracic cage in a sagittal plane. The ribs will be counted inferiorly and laterally, until the 5th rib is identified in the midaxillary line. The latissimus dorsi (superficial and posterior) , teres major (superior) and serratus muscles (deep and inferior) will be then easily identifiable by U/S overlying the fifth rib.

Procedure: Thoracic paravertebral block(TPVB) group

Interventions

Thoracic paravertebral block group (TPVB) group: The midpoint of the transducer is to be placed in a longitudinal paramedian plane between two transverse processes.Tuohy needle will be introduced in a cephalad direction. The tip of the needle will be advanced under direct visualization until it pierces the superior costo-transverse ligament. When the needle tip is located immediately above the pleura, the needle is aspirated to confirm the absence of blood or air. Serratus anterior plane block group (SAP) group: The US probe will be placed over the mid-clavicular region of the thoracic cage in a sagittal plane. The ribs will be counted until the 5th rib is identified in the midaxillary line. The latissimus dorsi, teres major and serratus muscles will be then easily identifiable by US overlying the fifth rib. The needle will be introduced in-plane with respect to the US probe from supero-anterior to postero-inferior

Also known as: Serratus anterior plane block( SAP) group
Group I:Group II :

Eligibility Criteria

Age20 Years - 60 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Female patients
  • Breast surgery with or without axillary clearance.
  • Age from 20 to 60 years.
  • ASA I, II, III.

You may not qualify if:

  • Major reconstructive breast surgery.
  • Age younger than 20 or older than 60 years.
  • ASA IV, V.
  • Hypersensitivity to any drug to be used.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Ahmed Abdalla Mohamed

Cairo, 11451, Egypt

Location

Kasr Alainy Hospitals

Cairo, 11451, Egypt

Location

MeSH Terms

Interventions

Population Groups

Intervention Hierarchy (Ancestors)

DemographyPopulation Characteristics

Study Officials

  • Ahmed Abdalla, M.D

    Cairo University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Masking Details
•Patients will be randomly allocated to one of the two groups by sealed closed envelop technique
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Although thoracic epidural analgesia is the gold standard technique after breast surgery paravertebral block (PVB) has become a potential alternative approach. However, both techniques may be associated with serious complications such as pneumothorax, total spinal anaesthesia and inadvertent intravascular injection. Recently since the advent of ultrasound (US) in anaesthetic practice several interfascial plane blocks have been described. Serratus plane block is a novel interfascial plane block which can provide analgesia after breast surgery. The serratus anterior plane block is an interfascial plane block where the local anaesthetics are injected superficial to serratus anterior at the 5th rib level in the mid axillary line. The serratus plane block is a progression from Blanco's et al work with the Pecs I and II blocks by making the technique easier in its application using single injection and to lower the potential side-effects
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor of Anesthesia &I.C.U and Pain Clinic

Study Record Dates

First Submitted

December 29, 2017

First Posted

March 5, 2018

Study Start

January 4, 2018

Primary Completion

February 8, 2018

Study Completion

February 12, 2018

Last Updated

March 16, 2018

Record last verified: 2018-03

Data Sharing

IPD Sharing
Will not share

Via scholar Gate

Locations